10,11 The availability of an additional pharmacologic test would be most useful ... or even presumptive evidence, of a pheochromocytoma. In the case reported herein, adrenergic blockade was ...
Depending on the specific procedure you are having, you might have an imaging test, like computerized tomography (CT ... Laparoscopic versus open surgery for pheochromocytoma: a meta-analysis. BMC ...
Keytruda is also indicated for the treatment of patients with unresectable or metastatic melanoma, for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors express ...
Keytruda is also indicated for the treatment of patients with unresectable or metastatic melanoma, for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors express ...
The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date ...
The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic ...
The FDA has accepted the application for belzutifan for advanced, unresectable, or metastatic pheochromocytoma and paraganglioma.
The supplemental new drug application is based on data from the Phase 2 LITESPARK-015 trial.
A pheochromocytoma is a type of tumor found in the adrenal glands or certain nerve cells. These tumors are very rare but can cause dramatic symptoms because they tend to secrete large amounts of ...
The cobas liat test aims to improve patient outcomes by offering rapid, accurate results in decentralized and community-based settings for patients at risk for chlamydia, gonorrhea, and Mycoplasma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback